Raleigh, NC (PRWEB) December 03, 2013
David Pulman, former president of Global Manufacturing and Supply Chain Management at GlaxoSmithKline, has joined three other Triangle business leaders on the Board of Directors for North Carolina New Schools.
According to a press release written about the institution, North Carolina New Schools is a “public-private partnership that promotes education innovation aimed at developing the highly skilled workforce that North Carolina needs to thrive in the 21st century.”
The partnership accomplishes this by supporting the development of effective schools, districts, and regions and cultivating talented teachers and administrators, with the goal to helping public school students in North Carolina graduate with the skills they need to lead productive lives.
The new board members include David Pulman GSK as well as several other widely recognized business leaders, such as Ed Auslander, president and CEO of the LORD Corporation, a privately-held technology and manufacturing company; Richard Stevens, counsel at the law firm of Smith Anderson, Blount, Dorsett, Mitchell & Jernigan and a former North Carolina General Assembly senator; and Matt West, Founder and CEO of Intangibles, a sales and marketing consulting firm.
The new members are filling newly created seats on the 15-member board, which is led by Chairman Bob Greczyn, CEO Emeritus, Blue Cross and Blue Shield of North Carolina.
“I couldn’t be more excited to join the board of North Carolina New Schools,” said Dr. Pulman. “I look forward to working together with these distinguished education and business leaders to help transform the public school system in North Carolina.”
About David Pulman GSK
David Pulman had a 35 year career with GlaxoSmithKline, the final 10 years as President of Global Manufacturing & Supply (GMS). With responsibility for the supply of pharmaceuticals, biopharmaceuticals and consumer health products, operations were situated in c 40 countries with an internal manufacturing network of c 80 sites in addition to a substantial external network. With as cost base of c $7bn and staff of 26,000, GMS represented a significant activity for GSK. His current interests include not for profit work in the areas of heath and education, understanding the factors that influence organizational and personal excellence, modern trends in the global society and how to redefine a productive lifestyle in a post-employment environment.
For more information:
or Email: elyse(dot)evine(at)bm(dot)com